You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY21 is not expected to be complete until September, 2022.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

  1. Eye-readable Solution-based Dye Displacement Probe for Large-area Detection of Opioids

    SBC: Intelligent Optical Systems, Inc.            Topic: CBD20AT001

    Intelligent Optical Systems, Inc., in collaboration with Bowling Green State University, proposes to develop a field-rugged, eye-readable indicating spray solution that can immediately detect synthetic opioids over a large area of contamination (i.e., military vehicles, individual protective equipment, clandestine labs, etc.). The proposed chemosensor in a spray solution format will detect multipl ...

    STTR Phase I 2021 Department of DefenseOffice for Chemical and Biological Defense
  2. Computer Vision Image Interpretation for 3D Model Reconstruction

    SBC: TOYON RESEARCH CORPORATION            Topic: DTRA18B001

    Toyon Research Corporation (Toyon) and the University of California, Santa Barbara (UCSB) propose research, development, and demonstration of algorithms and an efficient software prototype for 3D model reconstruction using single images collected via remote sensing. In particular, the effort is focused on processing of high-resolution commercial satellite images for 3D reconstruction of buildings. ...

    STTR Phase II 2021 Department of DefenseDefense Threat Reduction Agency
  3. Integrated Circuits

    SBC: NU TREK INC            Topic: DTRA20B002

    The Nu-Trek team is proposing to develop µDet, a low Size, Weight, and Power (SWaP) read out integrated circuit (IC) for gamma and neuron detectors. µDet offers pulse shape digitization, which in turn enables gamma-neutron discrimination. This is a game changing capability that brings laboratory-level functionality to the field. In Phase I the Nu-Trek Team will develop a baseline design for the ...

    STTR Phase I 2021 Department of DefenseDefense Threat Reduction Agency
  4. Discrete 3-D Electronics for Mobile Radiation Detection Systems

    SBC: Radiation Detection Technologies, Inc.            Topic: DTRA18B002

    Phase II will utilize knowledge gained from phase I work to develop and execute a manufacturing process suitable for producing quantities of 3-D printed discrete circuits for radiation detection systems.  The goal is to support mobile radiation detection system requirements for high voltage, analog amplification, and MCA functionality to produce differential pulse height spectra in time sequence. ...

    STTR Phase II 2020 Department of DefenseDefense Threat Reduction Agency
  5. Marburg Virus Prophylactic Medical Countermeasure

    SBC: Flow Pharma, Inc.            Topic: CBD18A002

    Through this STTR contract, we propose to evaluate the efficacy of our vaccine, FlowVax Marburg, in nonhuman primates (NHPs). This will be achieved through four Tasks. In Task 1, we will manufacture the vaccine in a quantity sufficient for the animal studies. In Task 2, we will perform MHC genotyping on a representative population of NHPs and, based on results, select a set of MHC-matched NHPs for ...

    STTR Phase II 2020 Department of DefenseOffice for Chemical and Biological Defense
  6. Marburg Virus Prophylactic Medical Countermeasure

    SBC: MAPP BIOPHARMACEUTICAL, INC.            Topic: CBD18A002

    There are currently no vaccines or therapeutics available for Marburg Virus Disease (MVD). Given the specter of weaponization and the terrible morbidity and high mortality rate of MVD, this represents a critical threat to the operational readiness of the Warfighter. While traditional vaccines have contributed greatly to public health, they have some limitations especially in the context of operati ...

    STTR Phase II 2020 Department of DefenseOffice for Chemical and Biological Defense
  7. Novel Circulating RNA-based Markers as Diagnostic Biomarkers of Infectious Diseases

    SBC: CFD Research Corporation            Topic: CBD18A001

    In resource limited settings, rapid and accurate diagnosis of infections is critical for managing potential exposures to highly virulent pathogens, whether occurring from an act of bioterrorism or a natural event. This is especially important for hard to detect intracellular bacterial and alphavirus infections, that overlap symptomatically and often treated empirically due to a lack of reliable an ...

    STTR Phase II 2020 Department of DefenseOffice for Chemical and Biological Defense
  8. Hardened, Optically-Based Temperature Characterization of Detonation Environments

    SBC: SA Photonics, Inc.            Topic: DTRA19B001

    Improving the effectiveness of counter-WMD operations requires improved understanding of weapon-target interaction. Specifically, time-resolved measurements of temperature and composition are required to allow temporal evolution of a detonation fireball. To address this need, SA Photonics will develop MONITOR, a laser-based temperature diagnostic that will enable wide dynamic range temperature mea ...

    STTR Phase I 2020 Department of DefenseDefense Threat Reduction Agency
  9. A Novel, Microscale, Distributable Sensor Technology for Ionizing Radiation

    SBC: CFD Research Corporation            Topic: DTRA14B004

    Terrorist use of radioactive nuclear materials via nuclear and/or radiological dispersion devices (dirty bombs) is a serious threat. Therefore, it is crucial to detect proliferation of nuclear material. Critical challenges include: (a) high sensitivity detection of signature emissions from radioactive isotopes, and (b) cost-effectiveness for deployment of sensor networks across large storage facil ...

    STTR Phase II 2019 Department of DefenseDefense Threat Reduction Agency
  10. Marburg Virus Prophylactic Medical Countermeasure

    SBC: Flow Pharma, Inc.            Topic: CBD18A002

    Flow Pharma, Inc. is a biotechnology company in the San Francisco Bay Area developing fully synthetic cytotoxic T lymphocyte (CTL)stimulating peptide vaccines for Marburg virus. The FlowVax vaccine platform allows us to create dry powder formulations of biodegradablemicrospheres and TLR adjuvants incorporating class I and class II T cell epitopes. FlowVax vaccines can be designed for delivery by i ...

    STTR Phase I 2018 Department of DefenseOffice for Chemical and Biological Defense
US Flag An Official Website of the United States Government